1 not yet recruiting, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Terminated 1 |
Follow Genetic Predisposition: new trials by email Literature Review of Genetic Predisposition trials Research Report on Genetic Predisposition
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans Exendin 9-39, Saline - Genetic Predisposition, Type2diabetes | Phase 2 | Not yet recruiting | Mayo Clinic | 80 | 2026-10-01 | 2026-01-30 |
| Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria Lisinopril, Placebo Oral Tablet - HIV/AIDS, Albuminuria | Phase 2 | Terminated | Vanderbilt University Medical Center | 66 | 2021-04-01 | 2025-06-26 |
Genetic Predisposition to Disease (2) · Acquired Immunodeficiency Syndrome (1) · Albuminuria (1) · Kidney Diseases (1)
Disease Attributes (2) · Disease Susceptibility (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Blood-Borne Infections (1) · Communicable Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · HIV Infections (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infections (1) · Lentivirus Infections (1) · Male Urogenital Diseases (1)
Lisinopril (1) · Sodium Chloride (1) · exendin (9-39) (1)
Mayo Clinic (1) · Vanderbilt University Medical Center (1)
Nigeria (1) · United States (1)
Adrian Vella, MD (1) · C. William Wester, MD, MPH (1) · Muktar H. Aliyu, MD, DrPH (1)
U01DK112271 (1)